PVC-plasticizer DEHP in medical products: Do thin coatings really reduce DEHP leaching into blood?

Perfusion

Volumn 20, Issue 6, 2005, Pages 351-357

  Hildenbrand, Sibylle L ^a   Lehmann, Hans Dieter ^b   Wodarz, Roman ^a   Ziemer, Gerhard ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MAQUET Cardiopulmonary AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYVINYLCHLORIDE;

ARTICLE; BLOOD ANALYSIS; BLOOD COMPATIBILITY; BLOOD SAMPLING; BLOOD STORAGE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; EXTRACORPOREAL CIRCULATION; HEPARINIZATION; HUMAN; IN VITRO STUDY; LEACHING; MALE; MALE FERTILITY; MATERIAL COATING; METABOLITE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RODENT;

ANTICOAGULANTS; COATED MATERIALS, BIOCOMPATIBLE; DIETHYLHEXYL PHTHALATE; EXTRACORPOREAL CIRCULATION; HEPARIN; HUMANS; MATERIALS TESTING; PLASTICIZERS;

EID: 29244483935     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659105pf836oa     Document Type: Article

References (11)

1. Center for Devices and Radiological Health. US Food and Drug Administration: safety assessment of di(2-ethylhexyl) phthalate released from PVC medical devices. http://www.fda.gov/cdrh/ost/dehp-pvc.pdf; 2001.
2. Schulte-Hermann R, Parzefall W, Huber W. A comprehensive literature review and toxicological risk assessment of possible effects on reproduction of di(2-ethylhexyl) phthalate (DEHP) and its metabolites from PVC-containing medical devices. Report to Austrian Ministry for Social Security and Generations (BMSG), July 13th, 2001.
3. Department of Health and Human Services, US Food and Drug Administration: Public Health Notification. PVC devices containing the plasticizer DEHP http://www.fda.gov/cdrh/safety/dehp.html; 2001.
4. Kahl R, Degen G, Foth H et al. Stellungnahme der Beratungskommission der Sektion Toxikologie der Deutschen Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie (DGPT) zu möglichen Gesundheitsgefahren durch Di(2-ethylhexyl) phthalat (DEHP) aus Medizinprodukten in neonatalogischen Intensivstationen. Umweltmed Forsch Prax 2003; 8: 25-30.
5. Karle VA, Short BL, Martin GR et al. Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethyl-hexyl)phthalate. Crit Care Med 1997; 25: 696-703.
6. Wendel HP, Hildenbrand S, Wodarz R, Aebert H, Ziemer G. Heparin-coating decreases DEHP release from polyvinyl chloride. Eighteenth European Conference on Biomaterials including Third Young Scientists' Forum, Stuttgart, 1-4 October, 2003, Poster 115.
7. Gourlay T, Samartzis I, Stefanou D, Taylor K. Inflammatory response of rat and human neutrophils exposed to di-(2-ethyl-hexyl)-phthalate-plasticized polyvinyl chloride. Artif Organs 2003; 27(3): 256-60.
8. Ministry of Health, Labour and Welfare: Safety Division, Pharmaceutical and Food Safety Bureau, Notification Nr. 1017001 from 17 October, 2002.
9. Department of Health and Human Services, US Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation. Medical devices made with polyvinylchloride (PVC) using the plasticizer di-(2-ethylhexyl)phthalate (DEHP); draft guidance for industry and FDA. http://www.fda.gov/cdrh/ode/guidance/1407.pdf; 2001.
10. Weber N, Wendel HP, Ziemer G. Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption. Biomaterials 2002; 23: 429-39.
11. Weber N, Wendel HP, Ziemer G. Gene monitoring of surface-activated monocytes in circulating whole blood by using duplex RT-PCR. J Biomed Mater Res 2001; 56: 1-8.